Literature DB >> 8099724

Human melanoma cell line M14 secretes a functional interleukin 2.

A Alileche1, S Plaisance, D S Han, E Rubinstein, C Mingari, R Bellomo, C Jasmin, B Azzarone.   

Abstract

Interleukin 2 (IL2) is an important regulator of the immune system. In this report, we have analysed five human melanoma cell lines expressing the IL2R for their ability to secrete IL2. In the M14 melanoma cell line, we observed the appearance of the 0.9 kb transcript specific for the IL2 gene, 72 h after subculture, and the secretion of a biologically active IL2 which specifically sustains the proliferation of the IL2 dependent murine lymphoid cell line CTLL2. In M14 cells, IL2 gene activation is transient as in lymphoid cells but is not inhibited by the immunosuppressive drugs cyclosporine-A and FK506 which are effective on PHA-blasts. In M14 cells, recombinant IL2 (36 pM) induces the down modulation of ICAM-1 expression at the surface of M14 cells. Overnight incubation of these cells with polyclonal anti-IL2 antibodies leads to an increased expression of ICAM-1 and a decreased membrane detection of the IL2R alpha, suggesting the existence of an autocrine/paracrine loop involved in the surface expression of these antigens. A decreased expression of the ICAM-1 protein could help some melanoma cells to escape from cytolytic recognition and therefore favour their metastasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099724

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.

Authors:  Emily Y Jen; Nancy J Poindexter; Elizabeth S Farnsworth; Elizabeth A Grimm
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

2.  The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses.

Authors:  Brendon J Coventry; Martin L Ashdown
Journal:  Cancer Manag Res       Date:  2012-08-02       Impact factor: 3.989

3.  The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.

Authors:  T E Reichert; Y Kashii; J Stanson; A Zeevi; T L Whiteside
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

4.  Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

Authors:  M D Boyano; M D Garcia-Vázquez; T López-Michelena; J Gardeazabal; J Bilbao; M L Cañavate; A G Galdeano; R Izu; L Díaz-Ramón; J A Raton; J L Díaz-Pérez
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

5.  Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.

Authors:  Danielle Bartlett; Glen M Boyle; Mel Ziman; Sandra Medic
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

6.  Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.

Authors:  Xiaojing Li; Zhifeng Li; Xianping Li; Baoguo Liu; Zhijun Liu
Journal:  BMC Cancer       Date:  2017-05-22       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.